A Phase 1, open-label, multicentre study to compare the capsule and tablet formulations of AZD5363 and explore the effect of food on the pharmacokinetic exposure, safety and tolerability of AZD5363 in patients with advanced solid malignancies: OAK
Titel:
A Phase 1, open-label, multicentre study to compare the capsule and tablet formulations of AZD5363 and explore the effect of food on the pharmacokinetic exposure, safety and tolerability of AZD5363 in patients with advanced solid malignancies: OAK
Auteur:
Dean, Emma Banerji, Udai Schellens, Jan H. M. Krebs, Matthew G. Jimenez, Begona Brummelen, Emilie van Bailey, Chris Casson, Ed Cripps, Diana Cullberg, Marie Evans, Stephen Foxley, Andrew Lindemann, Justin Rugman, Paul Taylor, Nigel Turner, Guy Yates, James Lawrence, Peter